Discusses the causes and impact of dry mouth.
Discusses the management of dry mouth and Sjögren's.
Highlights those patients who should be referred to a specialist centre for management
Oral dryness is a very common condition presenting to a general dental practitioner or hospital specialist. The most common cause of oral dryness is drug related, however, patients with Sjögren's syndrome, a multisystem autoimmune condition, may present to their dentist rather than their GP complaining of dry mouth and dry eyes. This update article explores the causes of oral dryness and how to manage it. The update on Sjögren's syndrome explains the latest relevant diagnostic criteria, presenting signs, symptoms, investigations and management principles.
Subscribe to Journal
Get full journal access for 1 year
only $20.79 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Field E A, Fear S, Higham S M et al. Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice. Gerodontology 2001; 18: 21–24.
Scully C, Felix D H . Oral Medicine — Update for the dental practitioner. Dry mouth and disorders of salivation Br Dent J 2005; 199: 423–427.
Wolff A, Joshi R K, Ekstrom J et al. A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs R D 2017; 17: 1–28.
Villa A, Wolff A, Narayana N et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Dis 2016; 22: 365–382.
Villa A, Wolff A, Afraiman D et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Invest 2015; 19: 1563–1580.
Aliko A, Wolff A, Dawes C et al. World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 120: 185–206.
Challacombe S . The Challacombe Scale. Available at www.challacombescale.co.uk (accessed October 2017).
Chisholm D M, Mason D K . Labial salivary gland biopsy in Sjögren's Syndrome J Clin Pathol 1968; 21: 656–660.
Delli K, Dijkstra P U, Stell A J . Diagnostic properties of ultrasound of major salivary glands in Sjögren's syndrome: a meta-analysis Oral Dis 2015; 21: 792–800.
Astorri E, Sutcliffe N, Richards P et al. Ultrasound of the salivary glands is a strong predictor of labial gland biopsy histopathology in patients with sicca symptoms. J Oral Pathol Med 2016; 45: 450–454.
Jousse-Joulin S, Nowak E, Cornec D et al. Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability RMD Open 2017; 3: e000364.
Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–558.
Shiboski S C, Shiboski C H, Criswell L A et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64: 475–487.
Shiboski C H, Shiboski S C, Seror R et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome; A consensus and data-driven methodology Involving three International patient cohorts. Ann Rheum Dis 2017; 76: 9–16.
Barone F, Colafrancesco S . Sjögren's syndrome: from pathogenesis to novel therapeutic targets Clin Exp Rheumatol 2016; 34 (Suppl. 98): S58–S62.
Theander E, Vasaitis L, Baecklund E et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011; 70: 1363–1368.
Mercadante V, Al Hamad A, Lodi G, Porter S, Fedele S . Interventions for the management of radiotherapy-induced xerostomia and hypo salivation: A systematic review and meta-analysis. Oral Oncol 2017; 66: 64–74.
Frost P M, Shirlaw P J, Challacombe S J, Fernandes-Naglik L, Walter J D, Ide M . Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients. Oral Dis 2006; 12: 57–62.
Gottenberg J E, Ravaud P, Puéchal X et al.: Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren's syndrome: the JOQUER randomized clinical trial. JAMA 2014; 312: 249–258.
Mariette X, Ravaud P, Steinfeld S et al.: Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum 2004; 50: 1270–1276.
Moutsopoulos N M, Katsifis G E, Angelov N et al.: Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann Rheum Dis 2008; 67: 1437–1443.
Nocturne G, Cornec D, Seror R, Mariette X . Use of Biologics in Sjögren's Syndrome. Rheum Dis Clin North Am 2016; 42: 407–417
Bowman S J, Everett CC, O'Dwyer J L et al. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. Arthritis Rheumatol 2017; 69: 1440–1450.
Hackett K L, Deane K H O, Strassheim V A et al. Systematic review of non-pharmacological interventions for primary Sjögren's syndrome. Rheumatology 2015; 54: 2025–2032.
About this article
Cite this article
Shirlaw, P., Khan, A. Oral dryness and Sjögren's: an update. Br Dent J 223, 649–654 (2017). https://doi.org/10.1038/sj.bdj.2017.882
American Journal of Speech-Language Pathology (2020)